Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Additional Reading from MarketBeat Media The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Reported by Chris Markoch. Article Posted: 1/18/2026. 
Quick Look - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. That often means targeting companies with disruptive technology, exposure to an emerging trend, or a compelling turnaround story. Many of these firms will never scale or survive, but if one succeeds, investors can earn outsized returns. For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks. The ranking is based on the number of MarketBeat subscribers following each company. While popularity is no guarantee of success, it can provide additional conviction for some investors. Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's "Nvidia-killer" stock ideas. Click here for complete analysis. Some investors define penny stocks as any shares trading under $5. The stocks in this screener, however, follow the traditional definition: shares priced below $1. These names are highly volatile—do your own research and make sure any position fits your risk tolerance. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases such as influenza, norovirus and COVID-19. Unlike injected vaccines, Vaxart's tablet-based platform is designed to simplify distribution and improve global accessibility. The bull case for Vaxart rests on its innovative delivery approach. If the company secures FDA approval and successfully scales manufacturing and distribution, oral vaccines could reduce logistical barriers to mass immunization and create opportunities for licensing partnerships. Positive trial data or a commercial collaboration could materially change sentiment and valuation, given the stock's low base. Clinical risk, however, is the primary headwind. Vaxart has not yet brought a product to market, and vaccine development is expensive and unpredictable. Competition from established players with larger R&D budgets also limits visibility. For now, Vaxart is a long-term speculative bet on platform validation rather than near-term profitability. The MarketBeat analyst ratings for Vaxart show only a single analyst covering the stock, which can be a cautionary sign for investors. Institutional ownership is about 18%, and short interest is roughly 2%, which may limit some volatility relative to other penny names. Microvision: Developing Cost-Effective LiDAR Units For Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure and industrial sensing. Its hardware and software enable the precise 3D mapping needed for self-driving and advanced driver-assistance systems (ADAS). Microvision focuses on developing compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case for Microvision depends on two factors: continued progress toward vehicle automation and the ability to secure partnerships with major automotive manufacturers. If Microvision can demonstrate superior performance or cost advantages, it could land supply agreements or licensing deals that improve revenue visibility. The technology also has potential applications in robotics and smart-city infrastructure, adding optionality to the growth story. Despite the promise, Microvision faces stiff competition from LiDAR players such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ) and Ouster (NYSE: OUST). The path to profitability is uncertain, and recurring delays in commercial LiDAR adoption have frustrated investors. MVIS is covered by three analysts and carries a consensus price target of $2.50, implying a roughly 169% upside from its Jan. 15 closing price. Still, Microvision has relatively low institutional ownership (around 30%) and high short interest (around 21%), factors that can contribute to wide price swings. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization and digital asset management. The company helps organizations turn raw data into tradable, revenue-generating assets via its patented Datavault platform. By combining AI, blockchain and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems often overlook. The bullish thesis for Datavault AI hinges on its niche focus and scalability potential. As data becomes increasingly valuable, businesses—and potentially individuals—are seeking ways to monetize digital information securely. Datavault's tools could benefit from broader AI adoption and rising interest in data sovereignty. Early traction or strategic partnerships could catalyze investor confidence. Datavault AI still operates in a highly experimental space. Its business model is evolving and the path to meaningful revenue is unproven. Institutional ownership is under 1%, and short interest exceeds 16% as of this writing. Investors should view DVLT as a long-term, speculative position based on belief in the data-as-an-asset thesis rather than near-term earnings potential.
| 
